Mime therapy and neural mobilization for Bell's palsy treatment
Effects of Mime Therapy With and Without Neural Mobilization on Facial Symmetry, Synkinesis and Functional Abilities in Patients With Bell's Palsy.
This study is testing if combining Mime Therapy with Neural Mobilization can help people with Bell's Palsy improve their facial movement and symmetry better than standard treatment alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 20 Years to 40 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Kasur, Punjab Province) |
| Trial ID | NCT06459830 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effects of Mime Therapy combined with Neural Mobilization on facial symmetry, synkinesis, and functional abilities in patients suffering from Bell's Palsy. The study involves a randomized controlled design where participants receive either the combined therapy or a placebo mobilization alongside conventional treatment. The aim is to determine if the addition of neural mobilization enhances the benefits of mime therapy, which has been shown to activate facial muscles and improve function. The trial is conducted over a period of 10 days of drug therapy followed by 3 weeks of therapy.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20 to 40 with sub-acute Bell's Palsy lasting 3-6 months and moderate to severe facial weakness.
Not a fit: Patients with chronic Bell's Palsy, recurrent facial palsy, or those with underlying health conditions such as diabetes or autoimmune disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve facial symmetry and functional recovery in patients with Bell's Palsy.
How similar studies have performed: Previous studies have shown promising results for mime therapy and neural mobilization in improving facial function in Bell's Palsy, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Idiopathic bell's palsy. Age between 20 to 40 years. Both genders Sub-acute Bell's palsy lasting 3-6 months. Unilateral loss of facial weakness Intact taste sensation. House Brackman grade 4 and 5 (moderate to severe Bell's palsy) Exclusion Criteria: Facial palsy recurrence. Patients with Diabetes, Hypertension, and any Auto-immune disorder. Chronic bell's palsy patients Patients with upper motor neuron lesions. Other cranial nerves problem. Pregnancy. Dental metal prosthesis. Facial surgery Skin allergy on face. Patients with Ear infection. Patients with Ear implants. Any neuro-degenerative disorder. Patients with Herpes zoster, Otitis media and Ramsay Hunt syndrome
Where this trial is running
Kasur, Punjab Province
- DHQ, Kasur (Baba Bulleh Shah Hospital, District Kasur). — Kasur, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Saifa Zia — Riphah International University (Lahore)
- Study coordinator: wajiha shahid
- Email: wajishahid89@gmail.com
- Phone: 03214885079
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.